The present invention relates to an improved process for the preparation of 4-amino-N-((2R, 3S)-3-amino-2-hydroxy-4- phenylbutyl) -N - isobutylbenzene sulfonamide, compound of formula (5) and its subsequent conversion into HIV protease inhibitors viz Darunavir or Amprenavir.